The Ataxia Charlevoix Saguenay Foundation and NeuroSphere are pleased to announce a strategic and financial partnership of $200,000 to support Dr. Benoit Gentil’s research project. This partnership, described as innovative and with high potential, aligns perfectly with the respective missions of the Foundation which aims to support the development of a treatment for ARSACS and the NeuroSphere group, whose objective is to promote innovative projects in neuroscience. Communique.
A $200,000 Partnership between the Foundation and NeuroSphere
